In conclusion, due to the indolent nature of the disease and since renal LC accumulation can be completely reversed, early performance of renal biopsy and timely application of ASCT is of critical importance in maintaining renal function in LCDD.
Introduction
Gestational trophoblastic disease (GTD) is characterized by abnormal proliferation of trophoblast layer of the placenta and is rarely associated with nephrotic syndrome (NS). The precise pathogenetic relationship between GTD and glomerulonephritis is unclear due to the rarity of reported cases. There are only a few case reports in which GTD associated with NS has been histologically documented [1] [2] [3] [4] [5] [6] [7] .
Here, we describe a case of NS occurring with an invasive mole. The renal pathologic changes we observed were consistent with minimal change disease (MCD). Clinical features and time course may provide better evidence of the contribution of gestational trophoblastic neoplasia (GTN) to the generation of NS.
Case Report
A 51-year-old female presented with reported periods of amenorrhoea and vaginal bleeding for the 3months prior to presentation. At admission, her blood pressure was 180/110 mmHg, and a palpable mass was noted on the lower abdomen. Mild pretibial pitting oedema was noted, and her haemoglobin concentration was 13.6 g/dL (136 g/ L). Blood chemistry tests revealed levels of total serum protein of 6.3 g/dL (63 g/L), albumin 3.0 g/dL (30 g/L), total cholesterol 256 mg/dL (6.62 mmol/L), blood urea nitrogen (BUN) 14.6 mg/dL (5.21 mmol/L) and creatinine 1.1 mg/dL (97.24 mmol/L). In a 24-h urine specimen, 4811 mg of protein and 1209 mg of creatinine were measured. Tests for antistreptolysin-O, antinuclear antibody (ANA), venereal disease research laboratory (VDRL), hepatitis B surface antigen and antibody, and rheumatoid factor were all negative. Serum human chorionic gonadotropin (β-hCG) levels were elevated to 577 319 mIU/mL.
An abdominopelvic computed tomography (CT) scan confirmed an ∼9.0 × 17.5 × 17.3-cm vascular enhancing mass in the uterus with a relatively well-defined margin (Figure 1) . A total abdominal hysterectomy with a bilateral salpingo-oophorectomy was performed. Tumour cells were positive for β-hCG, which is an essential substance for diagnosing and monitoring disease, although it did not adequately characterize the malignant potential of this tumour. Grossly, the endometrium revealed multifocal dark grey haemorrhagic papillary projections. In the section, the cut surface showed an ill-defined, dark red haemorrhagic mass with multifocal yellowish granular foci and necrotic foci. Proliferated and atypical intermediate trophoblasts invaded the myometrial wall with a focal haemorrhage. Histologic changes were consistent with a diagnosis of invasive mole (Figure 1) .
A renal biopsy was performed to confirm the diagnosis of glomerulopathy. Light microscopy revealed that the glomeruli were normal in appearance. The capillary loops were even and thin. The tubules, interstitium and blood vessels were all unremarkable. Immunofluorescence studies for immunoglobulin G (IgG), IgA, IgM, C3, fibrinogen and C1q were all negative. Electron microscopy revealed the thickness of the basement membrane was within the normal range. The overlying epithelial cells were swollen, and a diffuse foot process fusion was observed. Vague, electron-dense deposit-like materials were focally noted within the basement membrane. Pathologic findings suggested MCD (Figure 2) . One month later, the patient's serum β-hCG levels were 36.5 mIU/mL, and a 24-h urine specimen revealed 1315 mg/day of protein loss. Two months later, serum β-HCG levels were <2 mIU/mL with no proteinuria. There was no evidence supporting recurrence or metastasis of the invasive mole for 1.5 years, and the patient currently appears to be free of clinical symptoms of MCD.
Discussion
GTD describes a variety of gynaecological tumours originating in the trophoblast layer, including hydatidiform mole (complete or partial), placental site trophoblastic tumour, choriocarcinoma and GTN. Complete and partial hydatidiform moles are non-invasive and account for 80% of GTD cases. Invasive moles that have malignant potential for local invasion and distant metastasis cause most cases of localized GTN [8] . Whether it is possible to classify an invasive mole as an absolute malignant tumour is debatable. The malignant transformation of trophoblastic tissue is probably capable of causing a paraneoplastic phenomenon. Paraneoplastic phenomena are mediated by humoral factors or by an immune response to malignant cells without obvious alternative aetiology, and they usually present with malignancy. Sometimes, such phenomena are noted prior to the diagnosis of malignancy. A number of different types of glomerular disease, nephrotic or nephritic, may be associated with malignancy. Effective treatment of the tumour generally leads to remission of the glomerular injury in these settings.
A common cause of NS during pregnancy is pre-eclamptic nephropathy [9] . NS occurring in GTD patients is rarely reported [1] [2] [3] [4] 6, 7] . Interestingly, GTN had a tendency to be associated with membranous glomerulonephritis (MGN), according to the two cases presented earlier [2, 6] . Those reports of MGN described the regression by tumour resection alone, supporting that malignant trophoblastic tissue itself, or neoplastic antigens, is responsible for the development of MGN. We did not find any evidence of MGN by microscopic studies. The normal thickness of the glomerular basement membrane and foot process fusions were consistent findings of MCD. MCD may occur in association with haematologic malignancies, lymphoma or leukaemia [10] . Toxic lymphokines released from abnormal T cells may initiate glomerular injury, increasing the permeability of the glomeruli and capillaries in these disorders. Solid tumours are more commonly associated with an immune complexmediated disease such as MGN. However, rare cases of MCD associated with solid tumours have been reported. Clinical symptoms of MCD usually parallel the activity of the malignancy.
In our case, no clinical features of NS were noted before the diagnosis of malignancy, and a successful hysterectomy was followed by remission of MCD without medical treatment. We infer that MCD is secondary to an invasive mole. Although many uncertainties still exist about the pathogenetic mechanism, our report may provide the impetus for further research linking the pathogenesis of MCD to GTN.
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